» Articles » PMID: 28785035

Molecular and Physical Mechanisms of Fibrinolysis and Thrombolysis from Mathematical Modeling and Experiments

Overview
Journal Sci Rep
Specialty Science
Date 2017 Aug 9
PMID 28785035
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Despite the common use of thrombolytic drugs, especially in stroke treatment, there are many conflicting studies on factors affecting fibrinolysis. Because of the complexity of the fibrinolytic system, mathematical models closely tied with experiments can be used to understand relationships within the system. When tPA is introduced at the clot or thrombus edge, lysis proceeds as a front. We developed a multiscale model of fibrinolysis that includes the main chemical reactions: the microscale model represents a single fiber cross-section; the macroscale model represents a three-dimensional fibrin clot. The model successfully simulates the spatial and temporal locations of all components and elucidates how lysis rates are determined by the interplay between the number of tPA molecules in the system and clot structure. We used the model to identify kinetic conditions necessary for fibrinolysis to proceed as a front. We found that plasmin regulates the local concentration of tPA through forced unbinding via degradation of fibrin and tPA release. The mechanism of action of tPA is affected by the number of molecules present with respect to fibrin fibers. The physical mechanism of plasmin action (crawling) and avoidance of inhibition is defined. Many of these new findings have significant implications for thrombolytic treatment.

Citing Articles

A mathematical model of plasmin-mediated fibrinolysis of single fibrin fibers.

Ouedraogo R, Sowers H, Lynch S, Hudson N, Bannish B PLoS Comput Biol. 2024; 20(12):e1012684.

PMID: 39705285 PMC: 11703044. DOI: 10.1371/journal.pcbi.1012684.


Harnessing micrometer-scale tPA beads for high plasmin generation and accelerated fibrinolysis.

Osmond M, Dabertrand F, Quillinan N, Su E, Lawrence D, Marr D bioRxiv. 2024; .

PMID: 39574757 PMC: 11580863. DOI: 10.1101/2024.11.06.621942.


Deconstructing fibrin(ogen) structure.

Risman R, Sen M, Tutwiler V, Hudson N J Thromb Haemost. 2024; 23(2):368-380.

PMID: 39536819 PMC: 11786978. DOI: 10.1016/j.jtha.2024.10.024.


Unravelling the Antifibrinolytic Mechanism of Action of the 1,2,3-Triazole Derivatives.

Rabada Y, Bosch-Sanz O, Biarnes X, Pedreno J, Caveda L, Sanchez-Garcia D Int J Mol Sci. 2024; 25(13).

PMID: 39000111 PMC: 11241262. DOI: 10.3390/ijms25137002.


The effect of plasmin-mediated degradation on fibrinolysis and tissue plasminogen activator diffusion.

Bannish B, Paynter B, Risman R, Shroff M, Tutwiler V Biophys J. 2024; 123(5):610-621.

PMID: 38356261 PMC: 10938117. DOI: 10.1016/j.bpj.2024.02.002.


References
1.
Varju I, Tenekedjiev K, Keresztes Z, Pap A, Szabo L, Thelwell C . Fractal kinetic behavior of plasmin on the surface of fibrin meshwork. Biochemistry. 2014; 53(40):6348-56. DOI: 10.1021/bi500661m. View

2.
Collet J, Park D, Lesty C, Soria J, Soria C, Montalescot G . Influence of fibrin network conformation and fibrin fiber diameter on fibrinolysis speed: dynamic and structural approaches by confocal microscopy. Arterioscler Thromb Vasc Biol. 2000; 20(5):1354-61. DOI: 10.1161/01.atv.20.5.1354. View

3.
Yang Z, Mochalkin I, Doolittle R . A model of fibrin formation based on crystal structures of fibrinogen and fibrin fragments complexed with synthetic peptides. Proc Natl Acad Sci U S A. 2000; 97(26):14156-61. PMC: 18887. DOI: 10.1073/pnas.97.26.14156. View

4.
Wiman B, Collen D . On the kinetics of the reaction between human antiplasmin and plasmin. Eur J Biochem. 1978; 84(2):573-8. DOI: 10.1111/j.1432-1033.1978.tb12200.x. View

5.
LUCAS M, Fretto L, McKee P . The binding of human plasminogen to fibrin and fibrinogen. J Biol Chem. 1983; 258(7):4249-56. View